{"id":"https://openalex.org/W2416631382","doi":null,"title":"Drug-related hospital admissions--an overview of frequency and clinical presentation.","display_name":"Drug-related hospital admissions--an overview of frequency and clinical presentation.","publication_year":2006,"publication_date":"2006-09-01","ids":{"openalex":"https://openalex.org/W2416631382","mag":"2416631382","pmid":"https://pubmed.ncbi.nlm.nih.gov/17357592"},"language":"en","primary_location":{"id":"pmid:17357592","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17357592","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta poloniae pharmaceutica","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019490389","display_name":"Dorota Jenerowicz","orcid":"https://orcid.org/0000-0002-9833-2454","observed_orcids":["https://orcid.org/0000-0002-9833-2454"]},"institutions":[{"id":"https://openalex.org/I120230055","display_name":"Poznan University of Medical Sciences","ror":"https://ror.org/02zbb2597","country_code":"PL","type":"education","lineage":["https://openalex.org/I120230055"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Dorota Jenerowicz","raw_affiliation_strings":["Department of Dermatology, University of Medical Sciences, Przybyszewskiego 49, 60-355 Pozna\u0144, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, University of Medical Sciences, Przybyszewskiego 49, 60-355 Pozna\u0144, Poland","institution_ids":["https://openalex.org/I120230055"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019406650","display_name":"Magdalena M. Czarnecka-Operacz","orcid":"https://orcid.org/0000-0002-4662-2329","observed_orcids":["https://orcid.org/0000-0002-4662-2329"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Magdalena Czarnecka-Operacz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061878563","display_name":"Alina G\u00f3recka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alina G\u00f3recka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5057766780","display_name":"Maciej Stawny","orcid":"https://orcid.org/0000-0001-5106-5937","observed_orcids":["https://orcid.org/0000-0001-5106-5937","https://orcid.org/0000-0002-0829-4176"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maciej Stawny","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.381,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.63747376,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"63","issue":"5","first_page":"395","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.024399999529123306,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11033","display_name":"Contact Dermatitis and Allergies","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9509999752044678},{"id":"https://openalex.org/keywords/drug-related-hospital-admissions","display_name":"drug-related hospital admissions","score":0.8029999732971191},{"id":"https://openalex.org/keywords/drug-induced-skin-reaction","display_name":"drug-induced skin reaction","score":0.921999990940094},{"id":"https://openalex.org/keywords/maculopapular-rash","display_name":"maculopapular rash","score":0.9679999947547913},{"id":"https://openalex.org/keywords/angioedema","display_name":"angioedema","score":0.9309999942779541},{"id":"https://openalex.org/keywords/erythema-multiforme","display_name":"erythema multiforme","score":0.9980000257492065},{"id":"https://openalex.org/keywords/erythroderma","display_name":"erythroderma","score":0.9779999852180481},{"id":"https://openalex.org/keywords/lichenoid-eruption","display_name":"lichenoid eruption","score":0.777999997138977},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.8759999871253967},{"id":"https://openalex.org/keywords/antibiotics","display_name":"antibiotics","score":0.9319999814033508},{"id":"https://openalex.org/keywords/polypharmacy","display_name":"polypharmacy","score":0.6980000138282776},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.8889999985694885},{"id":"https://openalex.org/keywords/age-distribution","display_name":"age distribution","score":0.4779999852180481},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.6480000019073486},{"id":"https://openalex.org/keywords/renal-clearance","display_name":"renal clearance","score":0.47099998593330383}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9052697420120239},{"id":"https://openalex.org/C2781320243","wikidata":"https://www.wikidata.org/wiki/Q1363732","display_name":"Erythema multiforme","level":2,"score":0.7775274515151978},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.7042362093925476},{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.6224734783172607},{"id":"https://openalex.org/C2777489803","wikidata":"https://www.wikidata.org/wiki/Q14509067","display_name":"Exanthem","level":2,"score":0.5944772362709045},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5639699697494507},{"id":"https://openalex.org/C2779121184","wikidata":"https://www.wikidata.org/wiki/Q1166142","display_name":"Erythema","level":2,"score":0.538633406162262},{"id":"https://openalex.org/C2778784858","wikidata":"https://www.wikidata.org/wiki/Q1363741","display_name":"Erythroderma","level":2,"score":0.48473045229911804},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.46364107728004456},{"id":"https://openalex.org/C2779515644","wikidata":"https://www.wikidata.org/wiki/Q718675","display_name":"Drug eruption","level":3,"score":0.45902925729751587},{"id":"https://openalex.org/C2993432071","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Drug reaction","level":3,"score":0.4235679507255554},{"id":"https://openalex.org/C2781162121","wikidata":"https://www.wikidata.org/wiki/Q416132","display_name":"Betamethasone","level":2,"score":0.42102426290512085},{"id":"https://openalex.org/C2777520566","wikidata":"https://www.wikidata.org/wiki/Q2172867","display_name":"Topical steroid","level":2,"score":0.4115482568740845},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.4112963080406189},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.363703191280365},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.2724396586418152},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.16787683963775635},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005076","descriptor_name":"Exanthema","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:17357592","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17357592","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta poloniae pharmaceutica","raw_type":"Journal Article"},{"id":"mag:2416631382","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17357592","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2527424035","https://openalex.org/W2063591306","https://openalex.org/W4323293822","https://openalex.org/W4416038177","https://openalex.org/W2958179842","https://openalex.org/W7097323656","https://openalex.org/W2994010352","https://openalex.org/W2373218029","https://openalex.org/W2185359698","https://openalex.org/W2559076304"],"abstract_inverted_index":{"Adverse":[0],"drug":[1,177],"reactions":[2],"(ADR)":[3],"are":[4,17,32,210],"the":[5,44,50,85,181,189,196,200,211,215,227],"cause":[6],"of":[7,12,26,52,67,84,154,156,159,171,207,226],"hospital":[8,29],"admissions":[9],"for":[10,188],"millions":[11],"patients":[13,60,86,217],"every":[14],"year":[15],"and":[16,28,40,77,93,97,116,137,143,150,218],"believed":[18],"to":[19,58,129,176],"be":[20,130],"a":[21,54,65],"major":[22],"problem":[23],"in":[24,162,174,180,199,214],"terms":[25],"morbidity":[27],"expenses.":[30],"ADR":[31,194],"characterized":[33],"by":[34],"exceptional":[35],"variety,":[36],"both":[37],"considering":[38],"pathomechanism":[39],"clinical":[41,201],"symptoms.":[42],"During":[43],"time":[45],"period":[46],"between":[47],"2000-2004":[48],"at":[49],"Department":[51],"Dermatology":[53],"project":[55],"was":[56,179],"undertaken":[57],"monitor":[59],"who":[61],"were":[62,80,127,165],"hospitalized":[63],"as":[64,221,223],"result":[66],"ADR.":[68],"Within":[69],"five":[70],"years":[71],"57":[72],"patients,":[73],"including":[74],"30":[75],"men":[76],"27":[78],"women":[79],"observed.":[81],"The":[82,101,120,152,168,203],"majority":[83],"developed":[87],"maculaopapular":[88],"rash":[89],"(16),":[90],"urticaria":[91],"medicamentosa":[92],"Quincke's":[94],"edema":[95],"(16)":[96],"erythema":[98],"multiforme":[99],"(15).":[100],"other":[102,138],"cases":[103],"included":[104],"erythroderma":[105],"(5),":[106],"anaphylactic":[107],"shock":[108],"(2),":[109],"lichenoid":[110],"exanthem":[111],"(1),":[112],"bullous":[113],"eruption":[114],"(1)":[115],"Hoigne's":[117],"syndrome":[118],"(1).":[119],"most":[121,204],"probable":[122,205],"factors":[123],"producing":[124],"these":[125,208],"changes":[126,158,173],"concluded":[128],"non-steroid":[131],"antiinflammation":[132],"drugs":[133,139],"(33%),":[134],"antibiotics":[135],"(7%)":[136],"from":[140],"different":[141],"pharmacological":[142],"chemical":[144],"groups":[145,164],"(carbamazepine,":[146],"diltiazem,":[147],"hydrocortisone,":[148],"methotrexate":[149],"herbs).":[151],"frequency":[153],"occurrence":[155],"skin":[157,172],"particular":[160],"type":[161],"age":[163,182,190],"also":[166],"analyzed.":[167],"greatest":[169,197],"number":[170],"response":[175],"therapy":[178],"group":[183,191],"41":[184],"-":[185],"60,":[186],"while":[187],">":[192],"60":[193],"revealed":[195],"diversity":[198],"picture.":[202],"explanation":[206],"findings":[209],"polypragmasy":[212],"applied":[213],"elderly":[216],"interdrug":[219],"interaction":[220],"well":[222],"decreased":[224],"efficiency":[225],"organic":[228],"clearances.":[229]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}